Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Grallert

Holger Grallert, Schriesheim DE

Patent application numberDescriptionPublished
20110053188ENDOTOXIN DETECTION METHOD - The invention relates to a method for detecting endotoxins in a sample.03-03-2011

Holger Grallert, Regensburg DE

Patent application numberDescriptionPublished
20090202512PROTEINS FOR USE IN HUMAN AND ANIMAL STAPHYLOCOCCUS INFECTIONS - The present invention relates to a polypeptide termed ply_pitti26 comprising the sequence as depicted in SEQ ID NO:08-13-2009
20090304673Method of Treatment of Inflammatory Diseases - The present invention relates to a method of treatment of an inflammatory disease, in particular sepsis, in particular sepsis caused by gram-positive bacteria, wherein the method comprises the step of administering to a subject in need thereof a sufficient amount of bacterial cell wall degrading enzymes. The present invention relates further to pharmaceutical compositions comprising bacterial cell wall degrading enzymes.12-10-2009
20100216711Protease-Stable, Cell Wall-Lysing Enzymes - The present invention relates to a modified polypeptide with a biological activity to lyse cell walls of bacteria, wherein the polypeptide has no caspase, clostripain, enterokinase, factor Xa, granzyme B, 08-26-2010

Holger Grallert, Pentling DE

Patent application numberDescriptionPublished
20100028857Method for Detecting and for Removing Endotoxin - The invention relates to a method for identifying endotoxins for eliminating said endotoxins from a sample, with the aid of bacteriophage tail proteins.02-04-2010

Holger Grallert, Weilheim DE

Patent application numberDescriptionPublished
20110243916MODIFIED ENDOLYSIN PLY511 - The present invention relates to polypeptides with a changed amino acid sequence on at least one amino acid position compared to the amino acid sequence according to SEQ ID NO: 1. The present invention further relates to the nucleotide sequences encoding the polypeptide, vectors, comprising the nucleotide sequences and host cells for expression of the polypeptide. The present invention further relates to the use of the polypeptides as a human, veterinary medical or diagnostic substance, in food, in cosmetics, as disinfectant or in the environmental field.10-06-2011